Sequent Scientific Limited
NSE:SEQUENT.NS
213.12 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 13,697.31 | 14,209.09 | 14,101.72 | 13,520.35 | 11,605.13 | 10,205.29 | 8,419.57 | 8,944.72 | 6,295.87 | 4,406.56 | 4,537.74 | 3,260.86 | 3,458.1 | 3,116.65 | 2,844.48 | 1,440.21 | 747.96 | 447.21 |
Cost of Revenue
| 10,718.58 | 8,337.67 | 8,444.36 | 7,365.62 | 6,384.13 | 5,744.36 | 4,831 | 4,842.31 | 3,539.45 | 2,591.06 | 2,845.38 | 2,120.52 | 1,920.38 | 1,620.16 | 1,276.48 | 665.45 | 545.578 | 303.642 |
Gross Profit
| 2,978.73 | 5,871.42 | 5,657.36 | 6,154.73 | 5,221 | 4,460.93 | 3,588.57 | 4,102.41 | 2,756.42 | 1,815.5 | 1,692.36 | 1,140.34 | 1,537.72 | 1,496.49 | 1,568 | 774.76 | 202.382 | 143.568 |
Gross Profit Ratio
| 0.217 | 0.413 | 0.401 | 0.455 | 0.45 | 0.437 | 0.426 | 0.459 | 0.438 | 0.412 | 0.373 | 0.35 | 0.445 | 0.48 | 0.551 | 0.538 | 0.271 | 0.321 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 13.85 | 124.5 | 88.56 | 96.87 | 115.37 | 65.82 | 0 | 0 | 0 | 0 | 12.8 | 4.69 |
General & Administrative Expenses
| 0 | 540.26 | 500.31 | 455.06 | 380.48 | 312.59 | 297.95 | 266.5 | 149.28 | 107.46 | 112.3 | 62.4 | 0 | 0 | 0 | 0 | 28.22 | 13.74 |
Selling & Marketing Expenses
| 0 | 281.33 | 276.76 | 217.38 | 237.79 | 141.34 | 177.85 | 157.93 | 142.78 | 115.38 | 61 | 42.72 | 0 | 0 | 0 | 0 | 22.54 | 5.97 |
SG&A
| 2,901.81 | 821.59 | 777.07 | 672.44 | 618.27 | 453.93 | 475.8 | 424.43 | 292.06 | 222.84 | 173.3 | 105.12 | 0 | 0 | 0 | 0 | 50.76 | 19.71 |
Other Expenses
| 109.57 | 63.9 | -51.74 | -30.79 | -83.07 | -60.99 | -44.18 | -114.67 | -53.23 | -2.59 | -37.42 | -24.76 | 1,291.95 | 238.02 | 956.4 | 850.65 | 77.994 | 4.801 |
Operating Expenses
| 2,901.81 | 6,140.95 | 4,978.85 | 4,347.91 | 3,837.16 | 3,430.13 | 2,982.48 | 3,563.96 | 2,485.74 | 1,797.66 | 1,637.36 | 1,350.74 | 1,291.95 | 1,181.53 | 956.4 | 850.65 | 141.554 | 29.201 |
Operating Income
| 76.92 | -153.46 | 579.62 | 1,687.57 | 1,252.29 | 1,062.59 | 667.08 | -14.22 | -212.91 | -699.16 | -1,099.14 | -741.21 | 245.77 | 314.96 | 611.6 | -75.89 | 60.828 | 114.367 |
Operating Income Ratio
| 0.006 | -0.011 | 0.041 | 0.125 | 0.108 | 0.104 | 0.079 | -0.002 | -0.034 | -0.159 | -0.242 | -0.227 | 0.071 | 0.101 | 0.215 | -0.053 | 0.081 | 0.256 |
Total Other Income Expenses Net
| -623.38 | -1,223.12 | -50.32 | -321.28 | -311.54 | -473.75 | -430.63 | -406.08 | -351.52 | -496.88 | -979.47 | -308.82 | -299.9 | -280.07 | -216.65 | -50.52 | -23.747 | -2.951 |
Income Before Tax
| -546.46 | -1,376.59 | 533.86 | 1,366.29 | 940.75 | 588.84 | 236.45 | 6.38 | -169.64 | -633.19 | -1,099.14 | -727.5 | -54.13 | 34.89 | 394.95 | -126.41 | 37.081 | 111.416 |
Income Before Tax Ratio
| -0.04 | -0.097 | 0.038 | 0.101 | 0.081 | 0.058 | 0.028 | 0.001 | -0.027 | -0.144 | -0.242 | -0.223 | -0.016 | 0.011 | 0.139 | -0.088 | 0.05 | 0.249 |
Income Tax Expense
| -250.33 | -156.811 | 83.26 | 321.77 | 120.29 | 20.07 | 134.57 | -4.13 | 28.21 | 33.9 | 5.79 | -80.58 | -39.54 | 75.13 | 85.26 | 20.18 | 11.858 | 58.628 |
Net Income
| -358.69 | -1,211.599 | 409.55 | 954.42 | 699.05 | 486.6 | 4,215.66 | -138.24 | -221.56 | -107.38 | -1,104.93 | -646.94 | -13.99 | -1.76 | 374.17 | -146.59 | 25.218 | 85.75 |
Net Income Ratio
| -0.026 | -0.085 | 0.029 | 0.071 | 0.06 | 0.048 | 0.501 | -0.015 | -0.035 | -0.024 | -0.243 | -0.198 | -0.004 | -0.001 | 0.132 | -0.102 | 0.034 | 0.192 |
EPS
| -1.44 | -4.88 | 1.67 | 3.87 | 2.87 | 2 | 17.4 | -0.58 | -1.06 | -0.75 | -8.55 | -5.7 | -0.13 | -0.016 | 3.52 | -2.64 | 0.51 | 1.52 |
EPS Diluted
| -1.44 | -4.84 | 1.65 | 3.85 | 2.85 | 1.99 | 17.28 | -0.57 | -1.04 | -0.75 | -8.55 | -5.7 | -0.13 | -0.016 | 3.52 | -2.64 | 0.51 | 1.52 |
EBITDA
| 692.32 | -10.75 | 1,182.07 | 2,204.77 | 1,784.82 | 1,292.44 | 994.66 | 963.78 | 673.88 | 304.14 | 191.97 | -51.11 | 475.58 | 521.86 | 850.7 | -11.1 | 85.731 | 128.165 |
EBITDA Ratio
| 0.051 | -0.001 | 0.084 | 0.163 | 0.154 | 0.127 | 0.118 | 0.108 | 0.107 | 0.069 | 0.042 | -0.016 | 0.138 | 0.167 | 0.299 | -0.008 | 0.115 | 0.287 |